Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin With or Without Gemcitabine in CUP With Favorable Prognosis
NCT00126269Phase 3Unknown
- Sponsor
- Gustave Roussy
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gemcitabine in carcinoma of unknown primary (CUP) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Overall Survival. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00126269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126269.